share_log

Lifeist Announces Results of Annual General and Special Meeting of Shareholders

Lifeist Announces Results of Annual General and Special Meeting of Shareholders

Lifeist公佈年度股東大會和特別股東大會結果
GlobeNewswire ·  03/20 19:00

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced the results of the Company's Annual General and Special Meeting of the shareholders held on March 14, 2024 (the "AGSM").

多倫多,2024年3月20日(環球新聞專線)——Lifeist Wellness Inc.(“Lifeist” 或 “公司”)(多倫多證券交易所股票代碼:LFST)(法蘭克福:M5B)(OTCMKTS:LFSWF)(OTCMKTS:LFSWF)今天公佈了公司年度股東大會和特別股東大會的結果於 2024 年 3 月 14 日舉行(“AGSM”)。

A total of 191,161,948 common shares were represented in person or by proxy at the AGSM, representing 33.44% of the votes of all outstanding common shares of the Company as at the record date. Shareholders voted for the items of business brought before them at the AGSM as follows:

在AGSM上共有191,161,948股普通股代表或通過代理人出席,佔截至記錄日期公司所有已發行普通股選票的33.44%。股東們對在AGSM上提交給他們的業務項目進行了投票,具體如下:

  • The four nominees to the Company's Board of Directors, namely Meni Morim, Laurens Feenstra, Branden Spikes, and John Sinclair, were elected for the ensuing year.
  • Clearhouse LLP, Chartered Public Accountants were appointed as the Company's auditor to hold office until the next annual meeting of shareholders or until its successor is duly appointed, at a remuneration to be fixed by the Board.
  • The yearly shareholder approval required by TSXV rules for the continued use of the Company's Amended and Restated Stock Option Plan was obtained.
  • Shareholders also passed an ordinary resolution to approve a proposed consolidation of the issued and outstanding common shares of the Company on the basis of a consolidation ratio to be selected by the Board, within a range of between five (5) pre-consolidation common shares for one (1) post-consolidation common share and twenty (20) pre-consolidation common shares for one (1) post-consolidation common share.
  • The special resolution for the proposed sale of the Company's CannMart Group did not meet a super majority and therefore was not approved.
  • 公司董事會的四位提名人,即梅尼·莫里姆、勞倫斯·費恩斯特拉、布蘭登·斯皮克斯和約翰·辛克萊當選,任期爲次年。
  • Clearhouse LLP,特許公共會計師事務所被任命爲公司的核數師,任期至下一次年度股東大會或正式任命繼任者爲止,薪酬將由董事會確定。
  • TSXV規則要求的年度股東批准才能繼續使用公司的經修訂和重述的股票期權計劃。
  • 股東們還通過了一項普通決議,批准了根據董事會選擇的合併比率合併公司的已發行和流通普通股的提議,整合比例介於一(1)股合併後普通股的五(5)股合併前普通股和合並後一(1)股普通股的二十(20)股合併前普通股之間。
  • 擬議出售該公司CannMart集團的特別決議未獲得絕大多數通過,因此未獲得批准。

It is important to understand that the proposal to sell the CannMart Group was the result of careful consideration by the Company's Board of Director with input and advice from advisors and was aimed at securing the near- and long-term viability and success of Lifeist for the benefit of all shareholders.

重要的是要理解,出售CannMart集團的提議是公司董事會根據顧問的意見和建議仔細考慮的結果,旨在確保Lifeist的近期和長期生存能力和成功,造福所有股東。

The regulatory framework under which Canadian public cannabis companies operate has proven to be prohibitively expensive in terms of being able to turn a profit. Rather than representing discrete overhead costs (one set for being a public reporting company, the other set for being a licensed cannabis company), the regulatory burdens are significantly magnified by having to meet both sets of requirements simultaneously. This has been compounded by the fact that all public company costs such as audit and D&O insurance are significantly higher for cannabis companies compared to companies of similar size in other sectors.

事實證明,就盈利能力而言,加拿大上市大麻公司運營所依據的監管框架昂貴得令人望而卻步。由於必須同時滿足這兩套要求,監管負擔不但沒有代表離散的管理費用(一筆用於公開申報公司,另一部分用於持牌大麻公司),反而大大加劇了監管負擔。與其他行業類似規模的公司相比,大麻公司的所有上市公司成本,例如審計和D&O保險,都要高得多,這一事實使情況雪上加霜。

This experience has not been unique to Lifeist or CannMart: most Canadian public cannabis company, from the largest to the smallest, from generalists growing stadium-sized crops to specialists focused on extracts, distillates, beverages, and exotics, have been unable to turn a consistent profit. As a result, the entire public sector has been in a long and continuous bear market, with punishing capital rotations out of every stock in the category. The proposed sale of the CannMart Group was intended to divest Lifeist of the continued negative cash flow that the cannabis business has cost shareholders since inception.

這種經歷並不是Lifeist或CannMart所獨有的:大多數加拿大上市大麻公司,從最大到最小,從種植體育場大小作物的通才到專注於提取物、餾出物、飲料和異國情調的專家,都無法實現持續的盈利。結果,整個公共部門一直處於長期持續的熊市中,該類別中所有股票的資本輪換都受到懲罰。出售CannMart集團的提議旨在剝奪Lifeist自大麻業務成立以來給股東造成的持續負現金流。

The Board of Directors respects the decision of shareholders and shall make every possible effort and explore every alternative avenue to adapt and restructure the CannMart Group toward future success.

董事會尊重股東的決定,並將盡一切可能的努力探索所有替代途徑,調整和重組CannMart集團,以實現未來的成功。

Concurrently, Lifeist will continue to direct increased focus toward its Mikra and Aussie Vapes businesses and will provide more information about those developments in the near future. Initiatives presently underway at Lifeist's operating subsidiaries hold great promise for the realization of shareholder value, and we are dedicated to executing aggressively on that immediate strategy.

同時,Lifeist將繼續將更多精力放在其Mikra和Aussie Vapes業務上,並將在不久的將來提供有關這些發展的更多信息。Lifeist的運營子公司目前正在進行的舉措爲股東價值的實現帶來了巨大希望,我們致力於積極執行這一近期戰略。

About Lifeist Wellness Inc.

關於 Lifeist Wellness

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: Mikra, a biosciences and consumer wellness company developing and selling innovative products for cellular health; CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products; and Australian Vapes, one of Australia's largest online retailers of vaporizers and accessories.

Lifeist處於疫情後健康革命的最前沿,利用科學和技術的進步來建立突破性公司,改變人類健康。投資組合業務部門包括:開發和銷售細胞健康創新產品的生物科學和消費者健康公司Mikra;CannMart,該公司經營B2B批發分銷業務,促進向加拿大省政府控制委員會銷售休閒大麻,包括生產高利潤大麻2.0產品的BHO提取設施CannMart Labs;以及澳大利亞最大的蒸發器和配件在線零售商之一澳大利亞Vapes。

Information on Lifeist and its businesses can be accessed through the links below:

有關Lifeist及其業務的信息可以通過以下鏈接訪問:

Contact:
Meni Morim
CEO
Lifeist Wellness Inc.
Ph: 647-362-0390
Email: ir@lifeist.com

聯繫人:
Meni Morim
首席執行官
Lifeist健康公司
Ph:647-362-0390
電子郵件:ir@lifeist.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任,也未以任何方式批准或不批准本新聞稿的內容。

Forward Looking Information

前瞻性信息

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen.

本新聞稿包含適用證券法所指的 “前瞻性信息”。此處包含的所有非歷史性陳述均包含前瞻性信息。前瞻性信息可以通過單詞或短語來識別,例如 “可能”、“期望”、“可能”、“應該”、“將”、“計劃”、“預期”、“打算”、“潛在”、“提議”、“估計”、“相信” 或這些術語的否定詞、表達方式和語法變體,或某些事件或條件 “可能” 或 “將” 發生的陳述。

The forward-looking information contained herein, including, without limitation, statements related to a restructuring or other alternative arrangement with respect to the CannMart Group are made as of the date of this news release and are based on assumptions management believed to be reasonable at the time such statements were made, including without limitation, appropriate economic alternatives can be found to adapt and restructure CannMart, and Mikra and Aussie Vapes can become profitable in the short-term, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Such factors include, without limitation: the inability of the Company to complete a feasible and economic restructuring of the CannMart Group, in a timely manner, if at all, the Company's failure to develop its businesses as anticipated and to realize on the anticipated benefits from its increased focus on its Mikra and Aussie Vapes businesses unanticipated changes to current regulations that would adversely impact its businesses, unforeseen developments that would delay its businesses the ability to sell newly developed products, the risk that the expected demand for products in general and those of its businesses in particular does not develop as anticipated and risks relating to the Company's ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company's current MD&A filed under the Company's SEDAR+ profile at . Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

此處包含的前瞻性信息,包括但不限於與CannMart集團的重組或其他替代安排有關的陳述,是截至本新聞發佈之日作出的,其依據是管理層在發表此類聲明時認爲合理的假設,包括但不限於可以找到適當的經濟替代方案來調整和重組CannMart,Mikra和Aussie Vapes可以在短期內盈利,以及其他考慮因素據信視情況而定。儘管根據管理層目前獲得的信息,我們認爲這些假設是合理的,但無法保證此類預期會被證明是正確的。就其性質而言,前瞻性信息受固有的風險和不確定性的影響,這些風險和不確定性可能是一般性的,也可能是具體的,這些風險和不確定性可能導致預期、預測、預測、預測或結論不準確,假設可能不正確,目標、戰略目標和優先事項無法實現。各種因素,包括已知和未知的風險,其中許多是我們無法控制的,可能導致實際業績與本新聞稿中的前瞻性信息存在重大差異。這些因素包括但不限於:公司無法及時(如果有的話)完成對CannMart集團的可行經濟重組,該公司未能按預期發展業務,也未能實現因越來越關注Mikra和Aussie Vapes業務而產生的預期收益,對現行法規的意外變化將對其業務產生不利影響,不可預見的事態發展將推遲其業務銷售新開發產品的能力,風險是預期的總體而言,對產品的需求,尤其是對業務的需求沒有按預期發展,風險與公司執行業務戰略的能力及其可帶來的收益有關。其他風險因素還可以在公司SEDAR+簡介下提交的公司當前的MD&A中找到,網址爲。提醒讀者不要過分依賴前瞻性信息。除非適用法律要求,否則公司沒有義務更新或修改任何前瞻性信息,無論是由於新信息、未來事件還是其他原因。本新聞稿中包含的前瞻性陳述受本警示聲明的明確限制。

Source: Lifeist Wellness Inc.

資料來源:Lifeist Wellness


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論